Quality of life perception of type 1 diabetic patients treated with insulin analogs and receiving medication review with follow-up in a public health care service from Ponta Grossa-PR, Brazil
| Autor: | Josélia Borba Daher, Roberto Pontarolo, Astrid Wiens, Luana Lenzi, Aline Ansbach Garabeli |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Psychological intervention lcsh:RS1-441 030209 endocrinology & metabolism lcsh:Pharmacy and materia medica 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Pharmaceutical care Quality of life Diabetes mellitus Internal medicine Health care medicine 030212 general & internal medicine General Pharmacology Toxicology and Pharmaceutics Glycemic business.industry Diabetes mellitus type 1/treatment medicine.disease Confidence interval Diabetes mellitus type 1/treatment/quality of life chemistry Physical therapy Insulin analogs Pharmacotherapy follow-up Glycated hemoglobin business |
| Zdroj: | Brazilian Journal of Pharmaceutical Sciences, Volume: 52, Issue: 4, Pages: 669-677, Published: DEC 2016 Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 669-677 Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 669-677 Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 669-677 Brazilian Journal of Pharmaceutical Sciences Universidade de São Paulo (USP) instacron:USP Brazilian Journal of Pharmaceutical Sciences, Vol 52, Iss 4, Pp 669-677 |
| ISSN: | 2175-9790 1984-8250 |
| Popis: | Glycemic control in patients with diabetes mellitus type 1 (DM1) reduces the risk of complications but requires a rigorous health care routine. Thus, diabetes education is central to increasing treatment compliance and self-care practices. This study aimed to evaluate the quality of life (QoL) and glycemic control of DM1 patients being treated with insulin analogs and receiving medication review with follow-up. This was a transversal study that included 110 patients registered at the 3rd Health Regional of Ponta Grossa-PR, aged ≥ 18 years, and receiving pharmaceutical care for at least 1 year. The Diabetes Quality of Life Measure (DQOL)-Brazil was used to evaluate QoL. The data were statistically analyzed using SPSS version 17.0 with 95% confidence levels. Of the 110 patients, 58.2% were women. The average age was 33.7 years (±10.5), and the average glycated hemoglobin (HbA1c) value was 8% (±1.4). The mean total DQOL-Brazil score was 2.11 (95% confidence interval, 2.02 - 2.21). All DQOL-Brazil scores were lower in patients with HbA1c ≤ 8%, indicating a better QoL. Good glycemic control, thus, appears to have a positive influence on the QoL, and pharmaceutical interventions are able to contribute to the achievement of therapeutic targets. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|